EnGenome Eyes Return to US Market with Rare Disease Diagnostics Software

The Italian startup is expanding its eVai software platform to digenic rare disease diagnostics as it also broadens its marketing focus.

Related Keywords

New York ,United States ,Berkeley ,California ,Italy ,Portugal ,South Africa ,Spain ,Greece ,Chicago ,Illinois ,Italian ,America ,Ettore Rizzo ,Ivan Limongelli ,Susanna Zucca ,University Of California ,European Innovation Council ,College Of Wisconsin ,Association For Molecular Pathology ,University Of Pavia ,Mount Sinai Health System ,Us National Institutes Of Health ,American College Of Medical Genetics ,Italy Based Engenome ,Medical College ,Cofounder Ettore ,Critical Assessment ,Genome Interpretation ,Broad Institute Led Rare Genomes Project ,American College ,Medical Genetics ,Molecular Pathology ,Chief Technology Officer Ivan Limongelli ,Mastermind Genomic Search Engine ,